Telix Pharmaceuticals reported AUD5.65B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Cochlear AUD 17.05B 2.6B Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Integral Diagnostics AUD 1.08B 457.31M Dec/2024
Medical Developments International AUD 62.53M 563.29K Dec/2025
Mesoblast USD 1.75B 577.14M Jun/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Pacific Edge NZD 177.94M 16.27M Jun/2026
Paradigm Biopharmaceuticals AUD 145.7M 26.92M Dec/2025
PYC Therapeutics AUD 965.3M 209.97M Dec/2025
Ramsay Health Care AUD 7.93B 537.83M Dec/2025
ResMed USD 47.56B 4.96B Mar/2026